Bioactive
small molecules serve as invaluable biomarkers for recognizing
modulated organismal metabolism in correlation with numerous diseases.
Therefore, sensitive and specific molecular biosensing and imaging in vitro and in vivo are particularly critical
for the diagnosis and treatment of a large group of diseases. Herein,
a modular DNA tetrahedron-based nanomachine was engineered for the
ultrasensitive detection of intracellular small molecules. The nanomachine
was composed of three self-assembled modules: an aptamer for target
recognition, an entropy-driven unit for signal reporting, and a tetrahedral
oligonucleotide for the transportation of the cargo (e.g., the nanomachine
and fluorescent markers). Adenosine triphosphate (ATP) was used as
the molecular model. Once the target ATP bonded with the aptamer module,
an initiator was released from the aptamer module to activate the
entropy-driven module, ultimately activating the ATP-responsive signal
output and subsequent signal amplification. The performance of the
nanomachine was validated by delivering it to living cells with the
aid of the tetrahedral module to demonstrate the possibility of executing
intracellular ATP imaging. This innovative nanomachine displays a
linear response to ATP in the 1 pM to 10 nM concentration range and
demonstrates high sensitivity with a low detection limit of 0.40 pM.
Remarkably, our nanomachine successfully executes endogenous ATP imaging
and is able to distinguish tumor cells from normal ones based on the
ATP level. Overall, the proposed strategy opens up a promising avenue
for bioactive small molecule-based detection/diagnostic assays.